Biocompatibles Archive

Biocompatibles Archive

  1. SciClone Pharmaceuticals file for regulatory application to the Chinese State Food and Drug Administration for DC Bead

  2. Appointment of Tony Weir as Non Executive Director

  3. CellMed retained, put option waived / Application for Stroke Trial Submitted

  4. PRECISION 1 Data Results

  5. Abbott to focus on XienceTM V, not ZomaxxTM Drug Eluting Stent

  6. South-East Asia Distribution Agreement

  7. Interim Results

  8. Announcement of date for Interim Results for the half-year ended 30 June 2006

  9. Positive Data from Second Drug Eluting Bead Programme for Treatment of Metastatic Colorectal Cancer

  10. Issue of first instalment of deferred consideration shares for the acquisition of CellMed AG in 2005

  11. 2006 AGM Statement

  12. Clinical Trials Update

  13. China Distribution Agreement

  14. Positive Data announced at ASCO

  15. ASCO & WCIO

  16. 2005 Annual Report and Notice of 2006 Annual General Meeting

  17. 2005 Annual Report and Notice of 2006 Annual General Meeting

  18. New Distribution Agreements

  19. Appointment of New Chairman

  20. Statement from Abbott re Positive Results from Drug Eluting Stent Trial

  21. Start of Irinotecan Drug Eluting Bead Clinical Trial for Hepatic Colorectal Metastases

  22. Biocompatibles Preliminary Results

  23. Statements by Abbott Executives on Drug Eluting Stent Programme

  24. Start of PRECISION VI : Lung Cancer Trial

  25. Trading Statement - January 2006

  26. Appointment of Gerry Brown as Non-Executive Director

  27. Abbott to Acquire Guidant Vascular Business

  28. Abbott to Acquire Guidant Vascular Business

  29. Cosmetic Dermatology Out-Licence Agreement

  • Email alerts

    Stay up to date and register to receive the latest News and Press Releases by email.

    Email alerts RSS